Home › Opioid Overdose › NCT06827288
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Presented for ED care at ARMC * Age 18 or older * Probable OUD diagnosis * Speak and understand English or Spanish * Have capacity to give informed consent * Provide a signed and dated informed consent form
About the study
The ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder (OUD).
What is being tested
- SUN (behavioral)
- SUN + Telebridge (behavioral)
- ED-ITT (behavioral)
- ED-ITT + BHS (behavioral)
Sponsor: RAND · Participants: 500 · Started: Oct 4, 2024
Contact the study team
- Mariah Kalmin, PhD · Phone: 310-393-0411
- P'trice Jones, MS · Phone: 310-393-0411
Official record on ClinicalTrials.gov — NCT06827288
Locations in the U.S.
| California | Arrowhead Regional Medical Center, Colton |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.